1,898
Views
94
CrossRef citations to date
0
Altmetric
CRITICAL CARE

Acute recreational drug and new psychoactive substance toxicity in Europe: 12 months data collection from the European Drug Emergencies Network (Euro-DEN)

, , , , , , , & show all
Pages 893-900 | Received 09 Jul 2015, Accepted 25 Aug 2015, Published online: 26 Oct 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Venla Ellilä, Jonna Levola, Alexander Denissoff, Markus Partanen & Solja Niemelä. (2023) Psychotic-Like Experiences and Concurrent Substance Use Among People Who Use New Psychoactive Substances. Substance Use & Misuse 58:12, pages 1606-1614.
Read now
Courtney Weber, Jennifer L. Smith, Jessamine Soderstrom, Sally Burrows, David McCutcheon, Francois Oosthuizen & Daniel M. Fatovich. (2023) Analytically confirmed illicit and novel psychoactive drug use in Western Australian emergency departments: initial results from the Emerging Drugs Network of Australia (EDNA). Clinical Toxicology 61:7, pages 500-508.
Read now
Benjamin Crulli, Alison M. Dines, Georgina Blanco, Isabelle Giraudon, Florian Eyer, Matthias E. Liechti, Òscar Miró, Knut E. Hovda, Fridtjof Heyerdahl, Christopher Yates, Odd Martin Vallersnes, David M. Wood, Paul I. Dargan, Lukasz Anand, Kurt Anseeuw, Robertas Badaras, Jeffrey Bonnici, Miran Brvar, Blazena Caganova, Feriyde Calýskan, Alessandro Ceschi, Karam Chamoun, Laurence Daveloose, Miguel Galicia, Stefanie Geith, Ketevan Gorozia, Damjan Grenc, Femke Gresnigt, Laura Hondebrink, Gesche Jürgens, Jutta Konstari, Soso Kutubidze, Gabija Laubner, Evangelia Liakoni, Viesturs Liguts, Cathelijne Lyphout, Thomas MacMahon, Bruno Mégarbane, Adrian Moughty, Gabriela Viorela Nitescu, Roberta Noseda, Niall O'Connor, Raido Paasma, Juan Ortega Perez, Marius Perminas, Per Sverre Persett, Kristiina Põld, Jordi Puiguriguer, Julia Radenkova-Saeva, Jan Rulisek, Yasmin Schmid, Irene Scholz, Roberts Stašinskis, Jonas Surkus, Wesley van den Busken, Irma van den Hengel-Koot, Federico Vigorita, Wojciech Waldmanm, William Stephen Waring & Sergej Zacharov. (2022) Novel psychoactive substances-related presentations to the emergency departments of the European drug emergencies network plus (Euro-DEN plus) over the six-year period 2014–2019. Clinical Toxicology 60:12, pages 1318-1327.
Read now
Yasmin Schmid, Miguel Galicia, Severin B. Vogt, Matthias E. Liechti, Guillermo Burillo-Putze, Paul I. Dargan, Alison M. Dines, Isabelle Giraudon, Fridtjof Heyerdahl, Knut Erik Hovda, David M. Wood, Christopher Yates & Òscar Miró. (2022) Differences in clinical features associated with cannabis intoxication in presentations to European emergency departments according to patient age and sex. Clinical Toxicology 60:8, pages 912-919.
Read now
Michael E. Mullins. (2020) Fentanyl, Inc.. Clinical Toxicology 58:12, pages 1350-1350.
Read now
Òscar Miró, Paul I. Dargan, David M. Wood, Alison M. Dines, Christopher Yates, Fridtjof Heyerdahl, Knut Erik Hovda, Isabelle Giraudon & Miguel Galicia. (2019) Epidemiology, clinical features and management of patients presenting to European emergency departments with acute cocaine toxicity: comparison between powder cocaine and crack cocaine cases. Clinical Toxicology 57:8, pages 718-726.
Read now
Nicholas E. Webb, David M. Wood, Shaun L. Greene, Laura J. Hunter, John R. H. Archer, Alison M. Dines & Paul I. Dargan. (2019) Change in the new psychoactive substances associated with Emergency Department acute toxicity presentations associated with the introduction of the UK 2016 Psychoactive Substances Act. Clinical Toxicology 57:1, pages 36-41.
Read now
Daria Piacentino, Georgios D. Kotzalidis, Livia Longo, Antonio Pavan, Luciano Stivali, Guido Stivali, Stefano Ferracuti, Roberto Brugnoli, Paola Frati, Vittorio Fineschi, Paolo Girardi & Gabriele Sani. (2017) Body Image and Eating Disorders are Common among Professional and Amateur Athletes Using Performance and Image Enhancing Drugs: A Cross-Sectional Study. Journal of Psychoactive Drugs 49:5, pages 373-384.
Read now
Jose Orsini, Nanda Din, Ershad Elahi, Anthony Gomez, Salil Rajayer, Ryan Malik & Elie Jean. (2017) Clinical and epidemiological characteristics of patients with acute drug intoxication admitted to ICU. Journal of Community Hospital Internal Medicine Perspectives 7:4, pages 202-207.
Read now
Odd Martin Vallersnes, Per Sverre Persett, Elisabeth Leere Øiestad, Ritva Karinen, Fridtjof Heyerdahl & Knut Erik Hovda. (2017) Underestimated impact of novel psychoactive substances: laboratory confirmation of recreational drug toxicity in Oslo, Norway. Clinical Toxicology 55:7, pages 636-644.
Read now
Katrin Romanek, Jochen Stenzel, Sabrina Schmoll, Verena Schrettl, Stefanie Geith, Florian Eyer & Christian Rabe. (2017) Synthetic cathinones in Southern Germany – characteristics of users, substance-patterns, co-ingestions, and complications. Clinical Toxicology 55:6, pages 573-578.
Read now

Articles from other publishers (81)

Odd Martin Vallersnes, Alison M. Dines, David M. Wood, Fridtjof Heyerdahl, Knut Erik Hovda, Christopher Yates, Isabelle Giraudon, Blazena Caganova, Alessandro Ceschi, Miguel Galicia, Evangelia Liakoni, Matthias E. Liechti, Òscar Miró, Roberta Noseda, Per Sverre Persett, Kristiina Põld, Yasmin Schmid, Irene Scholz, Federico Vigorita & Paul I. Dargan. (2023) Self-discharge during treatment for acute recreational drug toxicity: an observational study from emergency departments in seven European countries. International Journal of Emergency Medicine 16:1.
Crossref
Òscar Miró, Guillermo Burillo-Putze, Yasmin Schmid, Emilio Salgado, Matthias E. Liechti, Alison M. Dines, Isabelle Giraudon, Fridtjof Heyerdahl, Knut Erik Hovda, Odd Martin Vallersne, Florian Eyer, David M. Wood, Christopher Yates, Paul I. Dargan & Miguel Galicia. (2022) Severity of emergency department presentations due to acute drug toxicity in Europe: a longitudinal analysis over a 6-year period (2014–2019) stratified by sex. European Journal of Emergency Medicine 30:1, pages 21-31.
Crossref
Matthew C. Hulme, Armita Hayatbakhsh, Rachel M. Brignall, Nicolas Gilbert, Andrew Costello, Christopher J. Schofield, David C. Williamson, E. Kate Kemsley, Oliver B. Sutcliffe & Ryan E. Mewis. (2021) Detection, discrimination and quantification of amphetamine, cathinone and nor ‐ephedrine regioisomers using benchtop 1 H and 19 F nuclear magnetic resonance spectroscopy . Magnetic Resonance in Chemistry 61:2, pages 73-82.
Crossref
Céline Eiden, Sophie Roy, Nicolas Malafaye, Michel Lehmann & Hélène Peyrière. (2022) Ten‐year trends in hospitalizations related to cocaine abuse in France. Fundamental & Clinical Pharmacology 36:6, pages 1128-1132.
Crossref
Ying Wang & Hao Zha. (2022) Neuroimaging for differential diagnosis of transient neurological attacks. Brain and Behavior 12:12.
Crossref
Jennifer L Smith, Jessamine Soderstrom, Andrew Dawson, Sam Alfred, Shaun Greene, Katherine Isoardi, David McCutcheon, Francois Oosthuizen, Nadine Ezard, Jonathon Burcham & Daniel M Fatovich. (2021) The Emerging Drugs Network of Australia: A toxicosurveillance system of illicit and emerging drugs in the emergency department. Emergency Medicine Australasia 34:1, pages 58-64.
Crossref
John R.H. Archer. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances 131 156 .
Christopher Yates & Piotr M. Kabata. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances 181 202 .
Harry Sumnall & Amanda Atkinson. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances 85 108 .
Rania Hussien, Maged El-Setouhy, Mohamed El Shinawi, Hazem Mohamed El-Hariri & Jon Mark Hirshon. (2021) Acute Toxic Effects of the New Psychoactive Substance “Voodoo” among Patients presented to the Poison Control Center of Ain Shams University Hospitals (PCC-ASUH), Egypt, during 2017. Substance Abuse Treatment, Prevention, and Policy 16:1.
Crossref
Jon Hjellum Vibeto, Odd Martin Vallersnes, Andrea Dobloug, Mette Brekke, Dag Jacobsen, Øivind Ekeberg & Knut Reidar Wangen. (2021) Treating patients with opioid overdose at a primary care emergency outpatient clinic: a cost-minimization analysis. Cost Effectiveness and Resource Allocation 19:1.
Crossref
Casper J. H. Wolf, Harmen Beurmanjer, Boukje A. G. Dijkstra, Alexander C. Geerlings, Marcia Spoelder, Judith R. Homberg & Arnt F. A. Schellekens. (2021) Characterization of the GHB Withdrawal Syndrome. Journal of Clinical Medicine 10:11, pages 2333.
Crossref
Céline Eiden, Marc Vincent, Chris Serrand, Anais Serre, Nathalie Richard, Marie‐Christine Picot, Elisabeth Frauger, Nathalie Fouilhé, Amélie Daveluy & Hélène Peyrière. (2020) Health consequences of cocaine use in France: data from the French Addictovigilance Network. Fundamental & Clinical Pharmacology 35:2, pages 455-465.
Crossref
David M. Wood & Paul I. Dargan. (2020) Regional, national and international datasets: How they improve our understanding of the acute harms associated with prescription medicine misuse. British Journal of Clinical Pharmacology 87:4, pages 1654-1659.
Crossref
Kerry A. Layne, Paul I. Dargan, Alison M. Dines, Craig Leaper, Christopher Yates, Knut Erik Hovda, Fridtjof Heyerdahl, John R.H. Archer, Isabelle Giraudon, David M. Wood, Lukasz Anand, Kurt Anseeuw, Robertas Badaras, Jeffrey Bonnici, Miran Brvar, Rachel Burke, Blazena Caganova, Alessandro Ceschi, Florian Eyer, Miguel Galicia, Stefanie Geith, Johan Gillebeert, Damjan Grenc, Ketevan Gorozia, Karim Jaffal, Gesche Jürgens, Jutta Konstari, Soso Kutubidze, Gabija Laubner, Evangelia Liakoni, Matthias Liechti, Viesturs Liguts, Cathelijne Lyphout, Bruno Mégarbane, Òscar Miró, Adrian Moughty, Roberta Noseda, Niall O'Connor, Raido Paasma, Juan Ortega Perez, Marius Perminas, Per Sverre Persett, Kristiina Põld, Jordi Puiguriguer, Julia Radenkova‐Saeva, Jan Rulisek, Yasmin Schmid, Irene Scholz, Radhika Sopirala, Roberts Stašinskis, Jonas Surkus, Ibolya Toth, Odd Martin Vallersnes, Federico Vigorita, Wojciech Waldman, W. Stephen Waring & Sergej Zacharov. (2020) Acute toxicity related to misuse (nonmedical use) of tramadol: Experience of the European Drug Emergencies Network Plus. British Journal of Clinical Pharmacology 87:4, pages 1668-1675.
Crossref
Craig Leaper, Alison M. Dines, Paul I. Dargan, Chris Yates, Knut Erik Hovda, Fridtjof Heyerdahl, Isabelle Giraudon & David M. Wood. (2021) Impact of pregabalin co-use in patients presenting with acute heroin toxicity to the European Drug Emergencies Network Plus project. European Journal of Emergency Medicine 28:2, pages 144-146.
Crossref
Wojciech Waldman, Piotr M. Kabata, Alison M. Dines, David M. Wood, Christopher Yates, Fridtjof Heyerdahl, Knut Erik Hovda, Isabelle Giraudon, Paul I. Dargan & Jacek Sein Anand. (2021) Rhabdomyolysis related to acute recreational drug toxicity—A Euro-DEN study. PLOS ONE 16:3, pages e0246297.
Crossref
Kenichi Tamama. (2021) Advances in drugs of abuse testing. Clinica Chimica Acta 514, pages 40-47.
Crossref
Hugo López-Pelayo, Julian Vicente, Ana Gallegos, Andrew McAuley, Yalçın Büyük, Martin White & Isabelle Giraudon. (2021) Mortality involving New Psychoactive Substances across Europe, 2016-2017. Emerging Trends in Drugs, Addictions, and Health 1, pages 100016.
Crossref
Te-I Weng, Lian-Yu Chen, Ju-Yu Chen, Pai-Shan Chen, Hsaio-Lin Hwa & Cheng-Chung Fang. (2020) Characteristics of analytically confirmed illicit substance-using patients in the Emergency Department. Journal of the Formosan Medical Association 119:12, pages 1827-1834.
Crossref
Michael Specka, Thomas Kuhlmann, Jürgen Sawazki, Udo Bonnet, Renate Steinert, Monika Cybulska-Rycicki, Helmut Eich, Benita Zeiske, Antje Niedersteberg, Luzia Schaaf & Norbert Scherbaum. (2020) Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment. Frontiers in Psychiatry 11.
Crossref
Luuk R. van den Bersselaar, Johannes G. van der Hoeven & Ben de Jong. (2020) Feeling Death, Being Alive. Addictive Disorders & Their Treatment Publish Ahead of Print.
Crossref
Rachel Sutherland, Steve Allsop & Amy Peacock. (2020) New psychoactive substances in Australia: patterns and characteristics of use, adverse effects, and interventions to reduce harm. Current Opinion in Psychiatry 33:4, pages 343-351.
Crossref
Anne Batisse, Celine Eiden, Helene Peyriere & Samira Djezzar. (2020) Use of new psychoactive substances to mimic prescription drugs: The trend in France. NeuroToxicology 79, pages 20-24.
Crossref
Harmen Beurmanjer, J. J. Luykx, B. De Wilde, K. van Rompaey, V. J. A. Buwalda, C. A. J. De Jong, B. A. G. Dijkstra & A. F. A. Schellekens. (2020) Tapering with Pharmaceutical GHB or Benzodiazepines for Detoxification in GHB-Dependent Patients: A Matched-Subject Observational Study of Treatment-as-Usual in Belgium and The Netherlands. CNS Drugs 34:6, pages 651-659.
Crossref
Eulalia Olesti, Jose Antonio Pascual, Mireia Ventura, Esther Papaseit, Magí Farré, Rafael Torre & Oscar J. Pozo. (2020) LC‐MS/MS method for the quantification of new psychoactive substances and evaluation of their urinary detection in humans for doping control analysis. Drug Testing and Analysis 12:6, pages 785-797.
Crossref
Laura Hondebrink, Johanna J. Nugteren‐van Lonkhuyzen, Claudine C. Hunault, Jorrit van den Berg, Daan van der Gouwe & Antoinette J. H. P. van Riel. (2020) New psychoactive substances (NPS) in the Netherlands: occurrence in forensic drug samples, consumer drug samples and poisons center exposures between 2013 and 2017. Addiction 115:4, pages 716-725.
Crossref
John R.H. Archer, Fiona Mendes, Simon Hudson, Kerry Layne, Paul I. Dargan & David M. Wood. (2020) Evaluation of long‐term detection trends of new psychoactive substances in pooled urine from city street portable urinals (London, UK). British Journal of Clinical Pharmacology 86:3, pages 517-527.
Crossref
David M. Wood & Paul I. Dargan. (2020) The challenge of the novel psychoactive substances: How have we responded and what are the implications of this response?. British Journal of Clinical Pharmacology 86:3, pages 407-409.
Crossref
I. Al-Banaa, L. Hawkins, S.L. Hill, D.J. Lupton, G. Jackson, E.A. Sandilands, S.M. Bradberry, J.P. Thompson, S. Rushton & S.H.L. Thomas. (2020) Effect of the UK Psychoactive Substances Act 2016 on episodes of toxicity related to new psychoactive substances as reported to the National Poisons Information Service. A time series analysis. International Journal of Drug Policy 77, pages 102672.
Crossref
Mariya Prilutskaya, Oleg Yussopov, Nikolay Negay, Kuanysh Altynbekov & Makpal Tokayeva. (2020) Prevalence of new psychoactive substances addiction: a hospital-based cross-sectional study. Journal of Clinical Medicine of Kazakhstan 1:55, pages 11-16.
Crossref
Abu Shafi, Alex J. Berry, Harry Sumnall, David M. Wood & Derek K. Tracy. (2020) New psychoactive substances: a review and updates. Therapeutic Advances in Psychopharmacology 10, pages 204512532096719.
Crossref
C. Verheij, P. P. M. Rood, C. K. Deelstra, M. L. L. Levendag, B. C. P. Koch, S. Polinder, S. C. E. Schuit & J. A. Haagsma. (2019) Emergency Department visits due to intoxications in a Dutch university hospital: Occurrence, characteristics and health care costs. PLOS ONE 14:12, pages e0226029.
Crossref
Marit Mæhle Grimsrud, Mette Brekke, Victoria Lykke Syse & Odd Martin Vallersnes. (2019) Acute poisoning related to the recreational use of prescription drugs: an observational study from Oslo, Norway. BMC Emergency Medicine 19:1.
Crossref
Victoria Lykke Syse, Mette Brekke, Marit Mæhle Grimsrud, Per Sverre Persett, Fridtjof Heyerdahl, Knut Erik Hovda & Odd Martin Vallersnes. (2019) Gender differences in acute recreational drug toxicity: a case series from Oslo, Norway. BMC Emergency Medicine 19:1.
Crossref
Odd Martin Vallersnes, Dag Jacobsen, Øivind Ekeberg & Mette Brekke. (2019) Mortality and repeated poisoning after self-discharge during treatment for acute poisoning by substances of abuse: a prospective observational cohort study. BMC Emergency Medicine 19:1.
Crossref
Norbert Wodarz, Stephan Mühlig & Rainer Thomasius. (2019) Neue Psychoaktive Substanzen: ein kurzgefasster Überblick. SUCHT 65:6, pages 362-370.
Crossref
Miguel Galicia, Paul I. Dargan, Alison M. Dines, Christopher Yates, Fridtjof Heyerdahl, Knut Erik Hovda, Isabella Giraudon, David M. Wood, Òscar Miró, Jacek Sein Anand, Jeffrey Bonnici, Blazena Caganova, Florian Eyer, Gesche Jürgens, Piotr Maciej Kabata, Evangelia Liakoni, Matthias E Liechti, Bruno Mégarbane, Adrian Moughty, Niall O'Connor, Raido Paasma, Per Sverre Persett, Kristiina Põld, Julia Radenkova–Saeva, Irene Scholz, Odd Martin Vallersnes, W Stephen Waring & Sergej Zacharov. (2019) Clinical relevance of ethanol coingestion in patients with GHB/GBL intoxication. Toxicology Letters 314, pages 37-42.
Crossref
Vincent T. Mensen, Annabel Vreeker, Johan Nordgren, Amanda Atkinson, Rafael de la Torre, Magi Farré, Johannes G. Ramaekers & Tibor M. Brunt. (2019) Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis. Psychopharmacology 236:9, pages 2677-2685.
Crossref
Mohammad Shokrzadeh, Reza Hoseinpoor, Danial Jafari, Azam Delaram, Akram Pouyan Sadr, Mehrnoosh Deylami & Yaghoub Shayeste. (2019) A Ten-Year Study of Drug Poisoning Cases Admitted to the Intensive Care Unit of 5 Azar Hospital in Gorgan, Iran. Journal of Clinical and Basic Research 3:2, pages 8-13.
Crossref
Paul Calle, Kristof Maudens, Sabine Lemoyne, Simon Geerts, Diederik Van Sassenbroeck, Peter Jensen, Jorne Van Overloop, Eric Deconinck & Peter Blanckaert. (2019) Lessons to be learned from toxicological analyses in intoxicated patients and seized materials at an electronic music dance festival. Forensic Science International 299, pages 174-179.
Crossref
David M. Wood, Luke De La Rue, Ali A. Hosin, Gesche Jurgens, Evangelia Liakoni, Fritdjof Heyerdahl, Knut Erik Hovda, Alison Dines, Isabelle Giraudon, Matthias E. Liechti & Paul I. Dargan. (2019) Poor Identification of Emergency Department Acute Recreational Drug Toxicity Presentations Using Routine Hospital Coding Systems: the Experience in Denmark, Switzerland and the UK. Journal of Medical Toxicology 15:2, pages 112-120.
Crossref
Nadia Benturquia, Lucie Chevillard, Christophe Poiré, Olivier Roussel, Camille Cohier, Xavier Declèves, Jean-Louis Laplanche, Mélanie Etheve-Quelquejeu, Huixiong Chen & Bruno Mégarbane. (2018) Is the 3,4-methylendioxypyrovalerone/mephedrone combination responsible for enhanced stimulant effects? A rat study with investigation of the effect/concentration relationships. Psychopharmacology 236:3, pages 891-901.
Crossref
T. Yamamoto, P. I. Dargan, A. Dines, C. Yates, F. Heyerdahl, K. E. Hovda, I. Giraudon, R. Sedefov & D. M. Wood. (2018) Concurrent Use of Benzodiazepine by Heroin Users—What Are the Prevalence and the Risks Associated with This Pattern of Use?. Journal of Medical Toxicology 15:1, pages 4-11.
Crossref
C . Lyphout, C. Yates, Z. R. Margolin, P. I. Dargan, A. M. Dines, F. Heyerdahl, K. E. Hovda, I. Giraudon, B. Bucher-Bartelson, J. L. Green & D. M. Wood. (2018) Presentations to the emergency department with non-medical use of benzodiazepines and Z-drugs: profiling and relation to sales data. European Journal of Clinical Pharmacology 75:1, pages 77-85.
Crossref
Lucio Oldani & Benedetta Grancini. 2019. Clinical Cases in Psychiatry: Integrating Translational Neuroscience Approaches. Clinical Cases in Psychiatry: Integrating Translational Neuroscience Approaches 115 135 .
Anaïs Serre, Céline Eiden, Vincent Gourhant, Marion Laureau, Damien Perier, Isabelle Giraud, Mustapha Sebbane & Hélène Peyrière. (2018) Implication de l’addictovigilance dans un service d’urgence pour la détection et le recueil des cas d’abus et de dépendance : bilan de 3 ans d’expérience. Therapies 73:6, pages 501-509.
Crossref
Vilakshan Alambyan, Jonathan Pace, Benjamin Miller, Mark L. Cohen, Sankalp Gokhale, Gagandeep Singh, Ming-Chieh Shun, Anthony Hammond & Ciro Ramos-Estebanez. (2018) The Emerging Role of Inhaled Heroin in the Opioid Epidemic. JAMA Neurology 75:11, pages 1423.
Crossref
Margaux Lafaurie, Liselotte Pochard, Clémence Lotiron, Laurent Molinier, Maryse Lapeyre-Mestre & Emilie Jouanjus. (2018) Identification of Somatic Disorders Related to Psychoactive Drug Use from an Inpatient Database in a French University Hospital. Clinical Drug Investigation 38:10, pages 977-982.
Crossref
Niamh Joyce, Pádraig MacNeela, Kiran Sarma, Graham Ryall & Eamon Keenan. (2017) The Experience and Meaning of Problematic ‘G’ (GHB/GBL) Use in an Irish Context: an Interpretative Phenomenological Analysis. International Journal of Mental Health and Addiction 16:4, pages 1033-1054.
Crossref
Hossein Molavi, Mostafa Zamani, Mozhgan Aghajanzadeh, Hamidreza Kheiri Manjili, Hossein Danafar & Akbar Shojaei. (2018) Evaluation of UiO-66 metal organic framework as an effective sorbent for Curcumin's overdose. Applied Organometallic Chemistry 32:4, pages e4221.
Crossref
Evangelia Liakoni, Fabienne Gartwyl, Meret Ricklin, Aristomenis K. Exadaktylos & Stephan Krähenbühl. (2018) Psychoactive substances and violent offences: A retrospective analysis of presentations to an urban emergency department in Switzerland. PLOS ONE 13:3, pages e0195234.
Crossref
Evangelia Liakoni, Christopher Yates, Alison M. Dines, Paul I. Dargan, Fridtjof Heyerdahl, Knut Erik Hovda, David M. Wood, Florian Eyer & Matthias E. Liechti. (2018) Acute recreational drug toxicity. Medicine 97:5, pages e9784.
Crossref
Evangelia Liakoni, Sabine Müller, Adrian Stoller, Meret Ricklin, Matthias E. Liechti & Aristomenis K. Exadaktylos. (2017) Presentations to an urban emergency department in Bern, Switzerland associated with acute recreational drug toxicity. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 25:1.
Crossref
Claire Norman & Geraldine A. Lee. (2017) A snapshot of novel psychoactive substances (legal highs) use in London. International Emergency Nursing 35, pages 56-58.
Crossref
Christopher Yates. (2017) The acute neuropsychiatric effects of cannabis and cannabinoid receptor agonists from a clinical perspective. Toxicology Letters 280, pages S71.
Crossref
Òscar Miró, Miguel Galicia, Paul Dargan, Alison M. Dines, Isabelle Giraudon, Fridtjof Heyerdahl, Knut E. Hovda, Christopher Yates, David M. Wood, Evangelia Liakoni, Matthias Liechti, Gesche Jürgens, Carsten Boe Pedersen, Niall O’Connor, Gerard Markey, Adrian Moughty, Christopher Lee, Patrick O’Donohoe, Jacek Sein Anand, Jordi Puiguriguer, Catalina Homar, Florian Eyer, Odd Martin Vallersnes, Per Sverre Persett, Lucie Chevillard, Bruno Mégarbane, Raido Paasma, W. Stephen Waring, Kristiina Põld, Christian Rabe & Piotr Maciej Kabata. (2017) Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse. Toxicology Letters 277, pages 84-91.
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Peter Neu. (2017) Gammahydroxybutyrat und seine psychiatrischen Implikationen. DNP - Der Neurologe & Psychiater 18:5, pages 22-26.
Crossref
Tiziano Acciavatti, Matteo Lupi, Rita Santacroce, Andrea Aguglia, Luigi Attademo, Laura Bandini, Paola Ciambrone, Giulia Lisi, Giovanni Migliarese, Federica Pinna, Diego Quattrone, Michele Ribolsi, Maria Salvina Signorelli, Salvatore Cal?, Fabrizio Schifano, Massimo di Giannantonio & Giovanni Martinotti. (2017) Novel psychoactive substance consumption is more represented in bipolar disorder than in psychotic disorders: A multicenter-observational study. Human Psychopharmacology: Clinical and Experimental 32:3, pages e2578.
Crossref
Anna Fantinati, Andrea Ossato, Sara Bianco, Isabella Canazza, Fabio De Giorgio, Claudio Trapella & Matteo Marti. (2017) 1-cyclohexyl-x-methoxybenzene derivatives, novel psychoactive substances seized on the internet market. Synthesis and in vivo pharmacological studies in mice. Human Psychopharmacology: Clinical and Experimental 32:3, pages e2560.
Crossref
Laurie Anderson, Heidi G Bell, Michael Gilbert, Julie E Davidson, Christina Winter, Monica J Barratt, Beta Win, Jeffery L Painter, Christopher Menone, Jonathan Sayegh & Nabarun Dasgupta. (2017) Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis. JMIR Public Health and Surveillance 3:1, pages e6.
Crossref
Alessandro Pirona, Alessandra Bo, Dagmar Hedrich, Marica Ferri, Nadine van Gelder, Isabelle Giraudon, Linda Montanari, Roland Simon & Jane Mounteney. (2017) New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe. International Journal of Drug Policy 40, pages 84-92.
Crossref
Thérèse Deborde & Anne-Claire Brisacier. (2017) Usage de cannabis et complications cardio-vasculaires et neuro-vasculaires. Psychotropes Vol. 22:3, pages 157-183.
Crossref
Minjee Kim, Sang Do Shin, Seungmin Jeong, Young Ho Kwak & Gil Joon Suh. (2017) Poisoning-induced Out-of-Hospital Cardiac Arrest and Outcomes according to Poison Agent. Journal of Korean Medical Science 32:12, pages 2042.
Crossref
Khalid A. Alsenedi & Calum Morrison. (2017) Comparison of six derivatizing agents for the determination of nine synthetic cathinones using gas chromatography-mass spectrometry. Analytical Methods 9:18, pages 2732-2743.
Crossref
Joanna Hockenhull, Kevin G. Murphy & Sue Paterson. (2017) An observed rise in γ-hydroxybutyrate-associated deaths in London: Evidence to suggest a possible link with concomitant rise in chemsex. Forensic Science International 270, pages 93-97.
Crossref
Rama M. Kamal, Martijn S. van Noorden, Wim Wannet, Harmen Beurmanjer, Boukje A. G. Dijkstra & Arnt Schellekens. (2016) Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention. CNS Drugs 31:1, pages 51-64.
Crossref
David M. Wood. 2017. Critical Care Toxicology. Critical Care Toxicology 1555 1586 .
C. Michael White. (2017) Pharmacologic, Pharmacokinetic, and Clinical Assessment of Illicitly Used γ -Hydroxybutyrate . The Journal of Clinical Pharmacology 57:1, pages 33-39.
Crossref
Evangelia Liakoni, Patrick C. Dolder, Katharina M. Rentsch & Matthias E. Liechti. (2016) Presentations due to acute toxicity of psychoactive substances in an urban emergency department in Switzerland: a case series. BMC Pharmacology and Toxicology 17:1.
Crossref
Varuni Asanka de Silva, Nicholas Jayasekera & Raveen Hanwella. (2016) Cannabis use among Navy personnel in Sri Lanka: a cross sectional study. BMC Research Notes 9:1.
Crossref
Evangelia Liakoni, Fabio Walther, Christian H. Nickel & Matthias E. Liechti. (2016) Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 24:1.
Crossref
Odd Martin Vallersnes, Dag Jacobsen, Øivind Ekeberg & Mette Brekke. (2016) Outpatient treatment of acute poisoning by substances of abuse: a prospective observational cohort study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 24:1.
Crossref
Odd Martin Vallersnes, Alison M. Dines, David M. Wood, Christopher Yates, Fridtjof Heyerdahl, Knut Erik Hovda, Isabelle Giraudon & Paul I. Dargan. (2016) Psychosis associated with acute recreational drug toxicity: a European case series. BMC Psychiatry 16:1.
Crossref
EB de Sousa Fernandes Perna, E Papaseit, C Pérez-Mañá, J Mateus, EL Theunissen, KPC Kuypers, R de la Torre, M Farré & JG Ramaekers. (2016) Neurocognitive performance following acute mephedrone administration, with and without alcohol. Journal of Psychopharmacology 30:12, pages 1305-1312.
Crossref
Wayne Hall & Michael Lynskey. (2016) Evaluating the public health impacts of legalizing recreational cannabis use in the United States. Addiction 111:10, pages 1764-1773.
Crossref
Markus R. Meyer. (2016) New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics. Archives of Toxicology 90:10, pages 2421-2444.
Crossref
David M. Wood & Paul I. Dargan. 2016. Forensic Toxicology: Drug Use and Misuse. Forensic Toxicology: Drug Use and Misuse 208 218 .
Elisabeth Leere Øiestad, Åse Marit Leere Øiestad, Astrid Gjelstad & Ritva Karinen. (2016) Oral fluid drug analysis in the age of new psychoactive substances. Bioanalysis 8:7, pages 691-710.
Crossref
David M. Wood. 2016. Critical Care Toxicology. Critical Care Toxicology 1 32 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.